Sentinels / Actor desk
Therapeutics Company Profile
organization · Registry status: unverified
9f4aee1c-707d-5951-94d3-d46ef2f5a7c5
Evidence, not intent.
Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.
No claim of complete coverage or live monitoring.
Observation window
UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.
Recent observations / timeline
The source record
200 distinct events shown, newest first. More matches exist; narrow the dates to inspect beyond the latest 200. Headlines may be generated summaries; inspect the source before repeating a claim.
SAB Biotherapeutics, Inc. (NASDAQ:SABSW) Stock Short Interest Report for October
Carisma Therapeutics (CARM) Expected to Post Quarterly Earnings on Thursday
Axsome Therapeutics (NASDAQ:AXSM) Stock Price Target Lowered at Royal Bank Of Canada
Electra Therapeutics, Inc. (NASDAQ:ETRA) Shares Shorted: Short Interest Down 41.7% in October
Cullinan Therapeutics (CGEM) Projected to Announce Earnings on Thursday
Axsome Therapeutics (NASDAQ:AXSM) Stock Gets Price Target Reduction from Robert W. Baird
Neuronetics (STIM) & Its Competitors Head to Head Comparison
Tectonic Therapeutic (TECX) Projected to Post Quarterly Earnings on Thursday
Teleflex (TFX) Set to Post Quarterly Earnings on Thursday
Equities Analysts Set Expectations for LENZ FY2026 Earnings
Keros Therapeutics (KROS) Projected to Post Quarterly Earnings on Wednesday
Teradyne, Inc. $TER Stake Lifted by Vise Technologies Inc.
Herc Holdings Inc. $HRI Stock Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,834 Shares of Stock
Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 1,452 Shares of Stock
Nurix Therapeutics (NASDAQ:NRIX) Stock: Insider Gwenn Hansen Sells 3,957 Shares
LENZ Therapeutics (NASDAQ:LENZ) Major Shareholder Sells $9,134,778.24 in Stock
CRISPR Therapeutics (NASDAQ:CRSP) Announces Earnings Results, Misses Expectations By $0.11 EPS
Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $170.00
Citic (OTCMKTS:CTPCY) Shares Gap Up – Still a Buy?
Tidewater (TDW) Set to Release Quarterly Earnings on Monday
Protara Therapeutics (TARA) Set to Announce Earnings on Monday
dailypolitical.com: Mukul Kumar, Pubmatic Company Profile, Jefferies Financial Group (tax fncact advertisers, wb 698 trade)
General Dynamics Corporation $GD Shares Sold by Sumitomo Mitsui Trust Group Inc.
Axsome Therapeutics (NASDAQ:AXSM) Posts Earnings Results, Beats Expectations By $0.38 EPS
Opus Genetics, Inc. (NASDAQ:IRD) Stock Has Average Target Price of $12.71
ThyssenKrupp AG Sponsored ADR (OTCMKTS:TKAMY) Stock Now Rated “Moderate Buy” by Wall Street Brokerages
Keros Therapeutics (NASDAQ:KROS) Stock Rating Cut to “Strong Sell” at Wall Street Zen
Grid Dynamics (NASDAQ:GDYN) Price Target Raised to $11.00
TeliaSonera AB (OTCMKTS:TLSNY) Stock Short Interest Report for October
Wall Street Zen Upgrades Turn Therapeutics (NASDAQ:TTRX) to “Hold”
Travere Therapeutics (TVTX) & The Competition Head to Head Analysis
Analyzing Travere Therapeutics (TVTX) and Its Rivals
Tesla, Inc. $TSLA Shares Sold by Profund Advisors LLC
2,065 Teradyne, Inc. $TER Shares Sold by Profund Advisors LLC
QuantumScape Corporation (NYSE:QS) Stock Has Average Target Price of $7.36
Relay Therapeutics (NASDAQ:RLAY) Stock: Insider Donald Bergstrom Sells 2,252 Shares
Yousif Capital Management LLC Purchases New Stake in Herc Holdings Inc. $HRI
Terex’s (TEX) “Buy” Rating Reiterated at Truist Financial
Compass Therapeutics, Inc. (NASDAQ:CMPX) Stock Has Average Price Target of $10.25 According to Brokerages
Foghorn Therapeutics (FHTX) vs. Its Rivals Financial Comparison
Quince Therapeutics, Inc. (NASDAQ:IRLA) Sees Large Growth in Short Interest
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Shares Shorted: Short Interest Down 67.9% in October
Kymera Therapeutics’ (KYMR) Buy Rating Reaffirmed at Truist Financial
TG Therapeutics (TGTX) Projected to Post Earnings on Monday
ThyssenKrupp AG Sponsored ADR (OTCMKTS:TKAMY) Stock Short Interest Report for October
Talanx AG (OTCMKTS:TLLXY) Shares Shorted: Short Interest Up 8,022.2% in October
Insider Buying: Tesco (LON:TSCO) Insider Buys 26 Shares of Stock
Teradyne (TER) Expected to Release Earnings on Tuesday
tickerreport.com: Vaibhav Taneja, Elon Musk, Deutsche Bank Aktiengesellschaft (tax econ price, tax econ price)
Torrid Holdings Inc. (NYSE:CURV) Stock Rated “Reduce” by Sell-Side Analysts
Tesla (NASDAQ:TSLA) Stock Bumped Down to “Sell” by Wall Street Zen
Tesla (NASDAQ:TSLA) Upgraded at BNP Paribas Exane
City Therapeutics (NASDAQ:CTY) Stock Moved Up to Hold by Wall Street Zen
TomTom (OTCMKTS:TMOAY) Share Price Breaks Below 200-Day Moving Average – Time to Sell?
Dynatronics (NASDAQ:DYNT) Share Price Breaks Above 200 Day Moving Average – Here’s Why
Accelerant (NYSE:ARX) Stock Price Breaks Above 200 Day Moving Average – Should You Sell?
Intensity Therapeutics (NASDAQ:INTS) Stock Price Up 2.1% – Time to Buy?
Trex (NYSE:TREX) Hits New 12-Month High – Here’s Why
Tesla, Inc. $TSLA Stock: New Harbor Financial Group LLC Lowers Stake
General Dynamics Corporation $GD Shares Bought by MBL Wealth LLC
Enlivex Therapeutics Stock Set to Reverse Split on Tuesday, October 27th (NASDAQ:ENLV)
Alimentation Couche-Tard (OTCMKTS:ANCTF) Shares Break Below Two Hundred Day Moving Average – Should You Sell?
Teradata (NYSE:TDC) Shares Break Above 200-Day Moving Average – Here’s Why
Teijin (OTCMKTS:TINLY) Shares Gap Up – What’s Next?
Tango Therapeutics (NASDAQ:TNGX) Shares Gap Down – Time to Sell?
QuantumScape (NYSE:QS) Releases Earnings Results, Beats Expectations By $0.03 EPS
Natera, Inc. $NTRA Holdings Increased by Nisa Investment Advisors LLC
AB Dynamics (LON:ABDP) Shares Break Above 50 Day Moving Average – Should You Sell?
Bluejay Diagnostics (NASDAQ:BJDX) Stock Price Down 3.7% – Time to Sell?
Tesla (NASDAQ:TSLA) Stock Price Down 3.1% – Should You Sell?
Tesla (NASDAQ:TSLA) Stock Rating Reaffirmed as Outperform by Royal Bank Of Canada
BNP Paribas Exane Upgrades Tesla (NASDAQ:TSLA) to Neutral
Anthem (NASDAQ:ANTX) Stock Price Up 5.6% – Time to Buy?
QuantumScape (NYSE:QS) Price Target Cut to $6.00 by Analysts at Robert W. Baird
Tron (NASDAQ:TRON) Stock Price Up 9.5% – Should You Buy?
Teradyne, Inc. $TER Stock: Lmcg Investments LLC Trims Holdings
Nightview Capital LLC Sells 2,517 Shares of Tesla, Inc. $TSLA
Astronics (OTCMKTS:ATROB) Stock Falls 6.2% – What’s Next?
Myriad Genetics (NASDAQ:MYGN) Shares Gap Up After Analyst Upgrade
SK Telecom Co., Ltd. $SKM Holdings Increased by Robeco Institutional Asset Management B.V.
W&T Offshore (WTI) Expected to Release Earnings on Thursday
Twilio Inc. $TWLO Stock Sold by Robeco Institutional Asset Management B.V.
Tenax Therapeutics (NASDAQ:TENX) Major Shareholder Adar1 Capital Management, Llc Acquires 336,528 Shares of Company Stock
Insider Buying: City Therapeutics (NASDAQ:CTY) Major Shareholder Purchases $3,060,000.00 in Stock
Alterity Therapeutics (NASDAQ:ATHE) Stock Jumps 0.8% – Still a Buy?
Natera (NASDAQ:NTRA) Price Target Raised to $500.00
Teekay (NYSE:TK) Share Price Crosses Above 200-Day Moving Average – Should You Sell?
Quad Graphics, Inc (NYSE:QUAD) Plans Quarterly Dividend of $0.10
Tenax Therapeutics (NASDAQ:TENX) Stock: Insider Adar1 Capital Management, Llc Acquires 336,528 Shares
Teijin (OTCMKTS:TINLY) Stock Falls 9.7% – What’s Next?
Latigo Biotherapeutics (NASDAQ:LTGO) Shares Up 5.5% – Here’s Why
Ovid Therapeutics (NASDAQ:OVID) Shares Climb 9.9% – Time to Buy?
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 7.4% – Here’s What Happened
Helen of Troy (NASDAQ:HELE) Stock Price Down 4% – Time to Sell?
AT&T (NYSE:T) Issues Earnings Results
Tapestry, Inc. $TPR Shares Sold by Axecap Investments LLC
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Stock Has Average Price Target of $66.60 According to Brokerages
Robeco Institutional Asset Management B.V. Sells 186,457 Shares of AT&T Inc. $T
Astronics Corporation $ATRO Stock Acquired by West Branch Capital LLC
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Expected to Rise, HC Wainwright Analyst Says
Team (NYSE:TISI) Stock Price Breaks Above 200-Day Moving Average – Here’s Why
XTEND AI Robotics (XTND) versus Its Competitors Financial Contrast
Tenon Financial LLC Purchases New Holdings in Tesla, Inc. $TSLA
Thales S.A. (OTCMKTS:THLLY) Stock Short Interest Drops 40.8%
Tesla, Inc. $TSLA Stock: Mezzasalma Advisors LLC Raises Stake
Herc Holdings Inc. (HRI) – What Are Researchers Saying About This Stock?
Nurix Therapeutics (NASDAQ:NRIX) Director Julia Gregory Sells 22,583 Shares of Company Stock
Federated Hermes (NYSE:FHI) Stock Gets Price Target Trim from TD Cowen
Cytokinetics (NASDAQ:CYTK) Upgraded at Wall Street Zen
Tenable Holdings, Inc. (NASDAQ:TENB) Stock Has Average Target Price of $34.68
Protara Therapeutics (NASDAQ:TARA) Stock Price Down 5.3% – Here’s Why
Palvella Therapeutics (NASDAQ:PVLA) Stock: Insider George Jenkins Sells 13,152 Shares
Serina Therapeutics, Inc. (NYSEAMERICAN:SER) Stock Short Interest Report for September
Serina Therapeutics, Inc. (NYSEAMERICAN:SER) Stock Short Interest Report for September
Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 3.8% – Time to Buy?
Viking Therapeutics (NASDAQ:VKTX) Hits New 52-Week Low – Time to Sell?
Immatics (NASDAQ:IMTX) Stock Price Up 4.8% – Should You Buy?
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.1% After Analyst Upgrade
Nurix Therapeutics (NASDAQ:NRIX) Shares Climb 4.1% After Analyst Upgrade
Tern (LON:TERN) Stock Jumps 19.9% – What’s Next?
Mineralys Therapeutics (NASDAQ:MLYS) Upgraded at UBS Group
Hemab Therapeutics (NASDAQ:COAG) Stock Rating Upgraded by Rodman & Renshaw
Odyssey Therapeutics (NASDAQ:ODTX) Stock Rating Upgraded by UBS Group
TeraWulf (NASDAQ:WULF) Stock Rating Upgraded by TD Cowen
Tectonic Therapeutic (NASDAQ:TECX) Upgraded to “Hold” at UBS Group
TeraWulf (NASDAQ:WULF) Upgraded to Strong-Buy at TD Cowen
Tesla Stock Earnings Estimates Boosted by Erste Group Bank
Tesla Stock Earnings Estimates Boosted by Erste Group Bank
Tokyo Tatemono Co., Ltd. (OTCMKTS:TYTMF) Stock Short Interest Report for September
Edison Inv. Res Comments on 70489 (PAA.TO) FY2026 Earnings
Capricor Therapeutics, Inc. (CAPR) – What Are Researchers Saying About This Stock?
Torm (NASDAQ:TRMD) Sets New 52-Week High – Still a Buy?
Tidewater Inc. (NYSE:TDW) Stock Has Average Price Target of $98.25 According to Analysts
Avalo Therapeutics (NASDAQ:AVTX) Hits New 1-Year Low – Should You Sell?
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Stock Has Consensus Price Target of $27.08 According to Brokerages
Trevi Therapeutics, Inc. (TRVI) – What Are Brokerages Saying About This Stock?
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Stock Rated “Moderate Buy” by Sell-Side Brokerages
Turn Therapeutics Inc. (TTRX) – What Are Brokerages Thinking About This Stock?
Travere Therapeutics, Inc. (NASDAQ:TVTX) Stock Has Consensus Price Target of $69.50
Oxford Metrics (LON:OMG) Stock: Insider Naomi Climer Buys 10,000 Shares
Tango Therapeutics (NASDAQ:TNGX) Stock Falls 9.4% – Time to Sell?
Avalo Therapeutics (NASDAQ:AVTX) Stock Falls 6.6% – Should You Sell?
Sensei Biotherapeutics (NASDAQ:FTH) Shares Down 7% – Should You Sell?
Halozyme Therapeutics (NASDAQ:HALO) Stock Price Expected to Rise, TD Cowen Analyst Says
PTC Therapeutics (NASDAQ:PTCT) Reaches New 12-Month Low – Time to Sell?
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Stock Has Average Target Price of $3.33
Abeona Therapeutics Inc. (ABEO) – What Are Brokerages Thinking About This Stock?
Erste Group Bank Boosts Earnings Estimates for Rio Tinto
Sitryx Reports Positive Phase 1b Results for First-in-Class Oral PKM2 Modulator SYX-5219 in Patients with Moderate to Severe Atopic Dermatitis
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Stock Has Average Price Target of $12.00 According to Brokerages
Verisk Analytics, Inc. (NASDAQ:VRSK) Stock Has Average Price Target of $226.71 According to Brokerages
Nektar Therapeutics (NASDAQ:NKTR) Now Covered by Analysts at Leerink Partners
AngioDynamics (NASDAQ:ANGO) Cut to “Hold” at Wall Street Zen
Tectonic Therapeutic (NASDAQ:TECX) Upgraded at Wall Street Zen
Talanx (ETR:TLX) Shares Climb 0.8% – Still a Buy?
Contineum Therapeutics (NASDAQ:CTNM) Reaches New 1-Year Low – Time to Sell?
Teradyne (NASDAQ:TER) Shares Down 4.7% – Here’s Why
Chemomab Therapeutics Ltd. Sponsored ADR (NASDAQ:CMMB) Shares Shorted: Short Interest Down 87.1% in September
Timken (NYSE:TKR) Stock Gets Price Target Reduction from Citigroup
Teijin (OTCMKTS:TINLY) Shares Up 6.6% – Here’s Why
Helen of Troy (NASDAQ:HELE) Shares Climb 5.9% – Still a Buy?
Tidewater Inc. (NYSE:TDW) Stock Has Consensus Price Target of $98.25
Fate Therapeutics, Inc. (NASDAQ:FATE) Stock Has Average Target Price of $5.90
ADC Therapeutics SA (NYSE:ADCT) Stock Has Consensus Target Price of $5.00 According to Brokerages
High Tide (NASDAQ:HITI) Raised to Buy at Wall Street Zen
Telos (NASDAQ:TLS) Raised to “Buy” at Wall Street Zen
Denali Therapeutics (NASDAQ:DNLI) Rating Lowered to “Sell” at Wall Street Zen
Protagonist Therapeutics (NASDAQ:PTGX) Stock Gets Downgrade from Wall Street Zen
Turn Therapeutics (NASDAQ:TTRX) Raised to “Hold” at Wall Street Zen
Ovid Therapeutics (NASDAQ:OVID) Stock Rated “Overweight” in New Coverage at Cantor Fitzgerald
Defence Therapeutics Inc. (OTCMKTS:DTCFF) Stock Short Interest Jumps 271.3%
EKF Diagnostics (LON:EKF) Stock Price Breaks Below 200-Day Moving Average – Here’s Why
Protagonist Therapeutics (NASDAQ:PTGX) Downgraded by Wall Street Zen to Buy
Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Raised to $11.00
Contineum Therapeutics, Inc. (NASDAQ:CTNM) Stock Has Consensus Target Price of $22.17 According to Brokerages
Prothena (NASDAQ:PRTA) Major Shareholder William Scully Purchases 125,000 Shares of Stock
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Stock Rated “Moderate Buy” by Wall Street Analysts
Grid Dynamics (NASDAQ:GDYN) Stock: Insider Yury Gryzlov Sells 4,849 Shares
Cognition Therapeutics (NASDAQ:CGTX) Stock Falls 2% – Here’s Why
Herald (LON:HRI) Shares Climb 0.8% – Should You Buy?
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
TeraGo (TSE:TGO) Sets New 52-Week High – What’s Next?
Elicio Therapeutics, Inc. $ELTX Shares Newly Purchased by Shah Capital Management
Definium Therapeutics (NASDAQ:DFTX) Stock Price Up 7.5% – Time to Buy?
AngioDynamics (NASDAQ:ANGO) Given Buy Rating at Canaccord Genuity Group
Veradermics (NYSE:MANE) Shares Up 3.4% – Here’s What Happened
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Downgraded by Zacks Research to Strong Sell
Rapport Therapeutics (NASDAQ:RAPP) CEO Abraham Ceesay Sells 1,147 Shares of Company Stock
Insider Buying: Dyne Therapeutics (NASDAQ:DYN) Director Purchases $40,000.00 in Stock
NeoGenomics, Inc. (NASDAQ:NEO) Stock Has Average Target Price of $17.67
Alimentation Couche-Tard Inc. (TSE:ATD) Stock Has Average Target Price of C$99.73 According to Analysts
Timken Company (The) (NYSE:TKR) Stock Has Consensus Target Price of $147.00 According to Analysts
Thales (OTCMKTS:THLEF) Shares Down 5.1% – What’s Next?
Erasca (NASDAQ:ERAS) Stock Price Up 5.8% – Time to Buy?
AngioDynamics (NASDAQ:ANGO) Stock Falls 7.1% – Should You Sell?
Aperam (OTCMKTS:APEMY) Stock Price Down 8.5% – What’s Next?
W&T Offshore (NYSE:WTI) Shares Gap Up – Should You Buy?
Tesco (OTCMKTS:TSCDY) Shares Gap Up – Here’s What Happened
Tesco (OTCMKTS:TSCDY) Shares Gap Up – Time to Buy?
Signals to inspect
Anomalies
Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.
Volume spike: 5 events in window (5.0x baseline of 1.0 expected)
Volume spike: 3 events in window (3.0x baseline of 1.0 expected)
New connection: 2 previously unseen co-actor(s) detected (known network: 119)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
New connection: 1 previously unseen co-actor(s) detected (known network: 118)
New connection: 2 previously unseen co-actor(s) detected (known network: 116)
New connection: 5 previously unseen co-actor(s) detected (known network: 113)
Volume spike: 2 events in window (2.0x baseline of 1.0 expected)
Volume spike: 5 events in window (5.0x baseline of 1.0 expected)
Narrative context
Unresolved threads
Latest 20 at most, across all dates. Stored narratives require human review.
Stored connections
Relationships
Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.
- Nasdaq→ co mention →Therapeutics Company Profile1091 evidence records
- Therapeutics Company Profile→ co mention →Securities and Exchange Commission799 evidence records
- Therapeutics Company Profile→ co mention →Geode Capital Management538 evidence records
- Zacks Research→ co mention →Therapeutics Company Profile405 evidence records
- Citigroup→ co mention →Therapeutics Company Profile312 evidence records
- JPMorgan Chase→ co mention →Therapeutics Company Profile298 evidence records
- Therapeutics Company Profile→ co mention →York To Royal Bank274 evidence records
- Morgan Stanley→ co mention →Therapeutics Company Profile257 evidence records
- Therapeutics Company Profile→ co mention →Goldman Sachs Group Inc254 evidence records
- Analysts At Wells Fargo Company→ co mention →Therapeutics Company Profile244 evidence records
- Needham Company→ co mention →Therapeutics Company Profile192 evidence records
- Barclays→ co mention →Therapeutics Company Profile182 evidence records
- Cantor Fitzgerald→ co mention →Therapeutics Company Profile179 evidence records
- Group On Financial→ co mention →Therapeutics Company Profile173 evidence records
- Therapeutics Company Profile→ co mention →Vanguard Group Inc173 evidence records
- Piper Sandler Companies→ co mention →Therapeutics Company Profile166 evidence records
- Therapeutics Company Profile→ co mention →Canaccord Genuity Group163 evidence records
- Stifel Nicolaus→ co mention →Therapeutics Company Profile155 evidence records
- Key Stories Impacting Jefferies Financial Group→ co mention →Therapeutics Company Profile153 evidence records
- Therapeutics Company Profile→ co mention →United States Senate153 evidence records
- Therapeutics Company Profile→ co mention →Raymond James Financial Inc144 evidence records
- Intech Investment Management→ co mention →Therapeutics Company Profile125 evidence records
- Ae Wealth Management→ co mention →Therapeutics Company Profile123 evidence records
- Therapeutics Company Profile→ co mention →Invesco122 evidence records
- Therapeutics Company Profile→ co mention →Team America116 evidence records
- Therapeutics Company Profile→ co mention →Elon Musk106 evidence records
- Millennium Management→ co mention →Therapeutics Company Profile103 evidence records
- Topco Ltd→ co mention →Therapeutics Company Profile98 evidence records
- Martin Eberhard→ co mention →Therapeutics Company Profile98 evidence records
- Marc Tarpenning→ co mention →Therapeutics Company Profile98 evidence records
- Vaibhav Taneja→ co mention →Therapeutics Company Profile95 evidence records
- Wolfe Research Fintech Forum→ co mention →Therapeutics Company Profile92 evidence records
- Therapeutics Company Profile→ co mention →Ovid Therapeutics Inc91 evidence records
- Therapeutics Company Profile→ co mention →Russell Investments Group Ltd In Alphabet85 evidence records
- Therapeutics Company Profile→ co mention →Advisory Services Network84 evidence records
- Caitong International Asset Management Co→ co mention →Therapeutics Company Profile84 evidence records
- Laurel Wealth Advisors→ co mention →Therapeutics Company Profile77 evidence records
- Dimensional Fund Advisors→ co mention →Therapeutics Company Profile76 evidence records
- Deutsche Bank Aktiengesellschaft Trading→ co mention →Therapeutics Company Profile75 evidence records
- Georges Bank→ co mention →Therapeutics Company Profile70 evidence records
- Therapeutics Company Profile→ co mention →Threadneedle Asset Management65 evidence records
- Therapeutics Company Profile→ co mention →Jason Ader William Blair64 evidence records
- Citadeland Marshall Wace→ co mention →Therapeutics Company Profile64 evidence records
- Capital Partners→ co mention →Therapeutics Company Profile62 evidence records
- Therapeutics Company Profile→ co mention →Kathleen Steven Sampson59 evidence records
- Therapeutics Company Profile→ co mention →Citadel Advisors57 evidence records
- Arthur Stevens Asset Management→ co mention →Therapeutics Company Profile54 evidence records
- Mirae Asset Global Investments Group→ co mention →Therapeutics Company Profile54 evidence records
- Therapeutics Company Profile→ co mention →Janus Henderson Group52 evidence records
- Boothbay Fund Management→ co mention →Therapeutics Company Profile51 evidence records
Ask this desk
Desk analyst
Read-only questions about Therapeutics Company Profile's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.
Operator sign-in is required. Sign in